Time matched metabolic cost. by JoEllen M. Sefton (16880253)

“…</p><p>Conclusions</p><p>Results suggest a powered ankle exoskeleton may decrease energy consumption during military relevant tasks when conducted in a laboratory environment. …”

Research design. by JoEllen M. Sefton (16880253)

“…</p><p>Conclusions</p><p>Results suggest a powered ankle exoskeleton may decrease energy consumption during military relevant tasks when conducted in a laboratory environment. …”

Time matched physiological strain. by JoEllen M. Sefton (16880253)

“…</p><p>Conclusions</p><p>Results suggest a powered ankle exoskeleton may decrease energy consumption during military relevant tasks when conducted in a laboratory environment. …”

Physiological strain. by JoEllen M. Sefton (16880253)

“…</p><p>Conclusions</p><p>Results suggest a powered ankle exoskeleton may decrease energy consumption during military relevant tasks when conducted in a laboratory environment. …”

Diagram of exercise intervention progression. by JoEllen M. Sefton (16880253)

“…</p><p>Conclusions</p><p>Results suggest a powered ankle exoskeleton may decrease energy consumption during military relevant tasks when conducted in a laboratory environment. …”

Perceived exertion. by JoEllen M. Sefton (16880253)

“…</p><p>Conclusions</p><p>Results suggest a powered ankle exoskeleton may decrease energy consumption during military relevant tasks when conducted in a laboratory environment. …”

Metabolic cost. by JoEllen M. Sefton (16880253)

“…</p><p>Conclusions</p><p>Results suggest a powered ankle exoskeleton may decrease energy consumption during military relevant tasks when conducted in a laboratory environment. …”

ASIR prediction from 2020 to 2030 by sex. by Majed M. Ramadan (22379116)

“…Bahrain also saw a significant increase in male Age-standardized death rate (ASDR), despite all other countries experiencing a decrease. …”

<i>Estimated metabolic rates among the simulation workflows</i>. by Israel Luis (13916706)

Average kidney and heart weight of rats. by Diana Bylan (20421873)

“…Dose-dependent experiments showed that COE (1 and 2μg/ml) induced a significant increase of phospho-(S473)-AKT along with a decrease in phospho (T180 + Y182) P38 levels.…”

<b>Empagliflozin Enhances Hepatic Glucose Production and Reduces Total-Body Norepinephrine Turnover Rate:</b> <b>A Randomized Trial</b> by Siham Abdelgani (17756772)

Data Sheet 1_Assessing the efficacy and safety of pentoxifylline in preventing chemotherapy-induced peripheral neuropathy and mucositis in breast cancer patients.pdf by Samar A. Dewidar (22425457)

“…</p>Conclusion<p>The co-administration of PTX with AC/T chemotherapy in breast cancer patients significantly decreases the incidence and postpones the onset of grade 2 or higher peripheral neuropathy and the incidence of mucositis without causing additional risks for the patients.…”

The lag phase defect is specific to transitions that require the production of FA, and correlates with FA concentration. by Zachary T. Hying (21512605)

The presence of lanthanum minimizes the lag phase and FA imbalance during the transition from formate to MeOH. by Zachary T. Hying (21512605)

Anti-cancer effect of TC extract on MMNK1 cell line. by Napat Armartmuntree (20571035)

PTSD symptom changes during Trauma-Focused Cognitive Behavioural Therapy (TF-CBT) in children and adolescents: a Single-Case Experimental Design study by Lieke H. Kooij (12895939)

“…However, symptoms do not decrease in a clear line, and individual symptom fluctuations are common.…”

ExaF contributes to FA homeostasis by lowering the FA concentration. by Zachary T. Hying (21512605)

Table 1_Prevalence and duration of clinical symptoms of pediatric long COVID: findings from a one-year prospective study.docx by Vita Perestiuk (22290208)

“…Multivariable logistic regression showed that older age was significantly associated with a higher risk of decreased physical activity (OR = 1.51, p = 0.038), lack of energy (OR = 2.00, p = 0.003), neurological symptoms (OR = 1.86, p = 0.007), headache (OR = 4.51, p = 0.000), memory impairment (OR = 5.12, p = 0.000), difficulty communicating (OR = 4.28, p = 0.000), difficulty concentrating (OR = 2.74, p = 0.001), cardiological symptoms (OR = 2.34, p = 0.022), sensory symptoms (OR = 2.66, p = 0.011), and dizziness (OR = 10.02, p = 0.034). …”

Table 3_Prevalence and duration of clinical symptoms of pediatric long COVID: findings from a one-year prospective study.docx by Vita Perestiuk (22290208)

“…Multivariable logistic regression showed that older age was significantly associated with a higher risk of decreased physical activity (OR = 1.51, p = 0.038), lack of energy (OR = 2.00, p = 0.003), neurological symptoms (OR = 1.86, p = 0.007), headache (OR = 4.51, p = 0.000), memory impairment (OR = 5.12, p = 0.000), difficulty communicating (OR = 4.28, p = 0.000), difficulty concentrating (OR = 2.74, p = 0.001), cardiological symptoms (OR = 2.34, p = 0.022), sensory symptoms (OR = 2.66, p = 0.011), and dizziness (OR = 10.02, p = 0.034). …”

Table 2_Prevalence and duration of clinical symptoms of pediatric long COVID: findings from a one-year prospective study.docx by Vita Perestiuk (22290208)

“…Multivariable logistic regression showed that older age was significantly associated with a higher risk of decreased physical activity (OR = 1.51, p = 0.038), lack of energy (OR = 2.00, p = 0.003), neurological symptoms (OR = 1.86, p = 0.007), headache (OR = 4.51, p = 0.000), memory impairment (OR = 5.12, p = 0.000), difficulty communicating (OR = 4.28, p = 0.000), difficulty concentrating (OR = 2.74, p = 0.001), cardiological symptoms (OR = 2.34, p = 0.022), sensory symptoms (OR = 2.66, p = 0.011), and dizziness (OR = 10.02, p = 0.034). …”